PMON71 Evaluation of a new transition organization for young adults with endocrine or metabolic diseases

OBJECTIVE: To evaluate the effect of a new care organisation on outcomes of transition success Design. Non-randomized controlled trial in a French University Hospital. METHODS: Patients transferred to adult care during the control period (04/2014-08/2016) and the intervention period (09/2016-06/2018) were included. The intervention is based on case management involving liaising with pediatric services, personalising care pathways, and liaising with structures outside hospital (general practitioner, educational and social sector). RESULTS: 202 patients were included (101 per period), the most represented pathologies were congenital and non-congenital hypopituitarism (respectively n=34 (17%) and n=45 (22%)) and thyroid diseases (n=21, 10%). Patients were aged 22.5 in median at 24 months post transfer where 12 were lost to follow up in the control group versus 9 with the intervention (p=0.49). The percentage of honoured consultation among those planned during 24 months was higher with intervention (p=0.0065). Patient satisfaction, physician trust, transfer delay did not differ between the groups. The incremental cost-effectiveness ratio was €179 per patient not lost to follow-up. CONCLUSIONS: At 24 months post transfer the rate of lost to follow-up does not differ significantly, but indicators of a steadier follow-up are increased and the intervention appears to be cost-effective. Presentation: Monday, June 13, 2022 12:30 p.m. - 2:30 p.m.